Export enquiry support for global pharmaceutical buyers seeking API impurities, working standards, reference standards, API intermediates, KSM intermediates, and custom synthesis materials from India.
Swapreen Pharma reviews international requirements with product identity, analytical documentation, destination, quantity, purity target, and timeline in one practical workflow.
Our export enquiry process is designed for buyers who need clear communication before procurement: target confirmation, catalogue or custom synthesis review, documentation expectations, and shipment-planning details.
API Impurities - Related substances, degradation products, metabolites, and impurity standards for analytical and QC use.
Reference and Working Standards - Defined materials for method validation, assay support, comparison, and routine laboratory workflows.
API / KSM Intermediates - API intermediate, KSM intermediate, development intermediate, and custom intermediate requirements.
Custom Synthesis - Unlisted impurities, rare compounds, NDSRI targets, metabolites, and special structures for feasibility review.
Select a country page for buyer-specific guidance on API impurities, reference standards, working standards, API intermediates, KSM intermediates, and custom synthesis enquiries.
Tell us your documentation needs during the quotation stage so technical and shipment planning can be reviewed together.
Certificate of Analysis discussion for applicable supplied materials.
HPLC, NMR, MS, IR, and purity information can be discussed by product and batch.
Mention safety data, handling, destination, and importer-side requirements early.
For non-catalogue targets, share structure, reference, requested scale, and purity target.
A complete RFQ helps us respond faster and reduces back-and-forth across time zones.
Compound name, CAS number, impurity designation, or structure.
Destination country, city, buyer type, and import-side context.
Requested scale, purity target, and intended analytical use.
CoA, HPLC, NMR, MS, IR, SDS, or other internal requirements.
Our team reviews availability or custom synthesis feasibility and replies with next steps.
Yes. Overseas pharmaceutical buyers, CROs, analytical laboratories, distributors, and sourcing teams can submit API impurity, working standard, API intermediate, KSM intermediate, and custom synthesis requirements for review.
Include the compound name, CAS number or structure, destination country, destination city, required quantity, purity target, intended use, documentation expectations, and timeline.
Applicable materials can be reviewed for CoA and analytical data such as HPLC, NMR, MS, and IR. Buyers can also mention SDS or shipment-document needs during enquiry.
Yes. Clearly defined non-catalogue compounds, rare impurities, metabolites, NDSRIs, and API intermediates and KSM intermediates can be reviewed when the structure, scale, purity target, and timeline are provided.
Include your destination country, compound identity, quantity, purity target, timeline, and documentation expectations.